Should Crescordia launch a resorbable product line?
Introduction
Crescordia is a company that produces products which range from artificial hips, scalpels, steel and titanium plates, and screws. The company is led by CEO Walsh, and it majors in fixation devices that are used by surgeons in repairing broken bones. Crescordia have products that are respected all over the world and ensures that the products are of high quality with no compromise. When any product is introduced in the market, the company takes the role of training surgeons on how to use the products to avoid deformities.
Problem Statement
Crescordia being a well-known producer of fixation devices has a challenge when it comes to launching new products in the market. This is because of its position in the market that is due to quality products that are introduced in the market. Launching resorbable products to the market will be of high benefits especially to children since surgeons hate it when removing implants from children. The resorbable products from Crescordia are not well proved to be effective for patients, and the company is in a dilemma whether to take the risk and introduce the resorbable products which might interfere with the reputation of the company. the
Solution
Due to the pain experienced by surgeons when performing a procedure twice on a patient, Crescordia should launch a resorbable product line with faith that it will work to the healing of patient and dissolve later. The fact that resorbable products were made of biodegradable polymers, they are strong enough to support the healing of the bone and later dissolve in the body. This allows for quick healing of the patient as surgeons are not required to operate a patient again to remove the screws and plates used to support patients’ bones. The technology that made the resorbable products a few years ago was not perfect which made the idea of resorbable products to be dismissed. With the current technology in Crescordia, resorbable plates and screws have been made and tested where their effectiveness is proved over the other steel and titanium products. The only place the resorbable products have not been tested in on the human body. Despite resorbable products being reactive in the human body, they are harmless as they dissolve.
Many people are confident that Crescordia can make a resorbable fixation system which means launching their products will be accepted by the surgeons in most hospitals. Orthopedic surgeons are eager to use the resorbable products, especially on children so that those children don’t have to undergo a second operation when removing the plates and screws. The benefit that will be associated with the launch of the resorbable product line includes better management of patients with fracture and fast healing. This is because the resorbable products are biodegradable which means they dissolve in the body of the patient after healing. This will ensure that a patient is not operated twice.
Another benefit of launching the product is that it will create a good reputation for Crescordia which will be the first company to launch workable resorbable products. There will be increased consumers of their products which will be profitable for the company.
Recommendations
For Crescordia company to benefit from the launch, it should first test the resorbable products with a real human so that its effectiveness can be justified. The company should consider testing with an old person rather than a child so that in case of any repercussion, the adult will have signed for himself, not a child who cannot consent.
The company should also look for cheaper material for making the resorbable products so that the company can meet the increased demand for the products bearing in mind that no other company is successful in making resorbable products.